Biotin and Thyroid Labs: Why Your Supplement May Be Skewing Your Results

High-dose biotin (≥5 mg/day, common in hair and nail supplements) can cause a falsely low TSH and falsely high T3 and T4 on standard immunoassay-based thyroid tests — results that mimic hyperthyroidism even in a healthy person. The FDA issued safety advisories in 2017 and 2019. The fix is simple: stop biotin at least 2–3 days before any thyroid blood draw, and tell your doctor if you take it.

Why biotin matters for your thyroid tests

If you take a biotin supplement for hair growth, nail strength, or general wellness, there's something you need to know before your next thyroid blood test: high-dose biotin can make your results look completely wrong.

This isn't a theoretical concern. The FDA has flagged it twice — in November 2017 and again in November 2019 [C1]. Clinicians have published case reports of patients being incorrectly diagnosed with hyperthyroidism, started on antithyroid medication, and worked up for Graves' disease — only to have everything normalize once their biotin supplement was stopped [C4]. In thyroid cancer surveillance, a falsely low thyroglobulin result from biotin interference could mask a real tumor recurrence [C8].

The supplement industry has made biotin doses creep dramatically upward. Hair and nail products marketed at cosmetic doses now routinely contain 2,500–10,000 mcg (2.5–10 mg) per capsule — far above the adequate intake of 30 mcg/day and well into the range where interference occurs [C5].

What the research actually shows

The interference is rooted in how most thyroid immunoassays work. Standard platforms from Roche, Siemens, and others use a streptavidin-biotin binding system as part of the assay architecture. Streptavidin, a protein derived from bacteria, binds biotin with near-perfect affinity — one of the strongest non-covalent interactions known in biology [C2].

Here's the problem: when a patient's blood contains excess biotin from supplements, that free biotin competes with the biotinylated antibody inside the assay. In sandwich assays (used for TSH), excess biotin blocks the streptavidin binding sites before the TSH-antibody complex can attach, producing a falsely low result. In competitive assays (used for free T3 and free T4), excess biotin paradoxically pushes results falsely high [C2, C3].

Ylli et al. 2021 demonstrated this directly. Thirteen healthy adults took 10 mg/day of biotin for eight days. On the Roche Cobas platform, significant changes in TSH, free T4, and total T3 appeared within hours of a biotin dose [C2]. The Abbott Architect and mass spectrometry platforms (which don't use streptavidin) showed no interference — but most clinical labs run Roche or Siemens [C2].

The clinical picture this creates is alarming in its specificity: low TSH, elevated free T4, elevated free T3. This is the textbook biochemical pattern of hyperthyroidism — and it's entirely artifactual when the patient simply took a biotin supplement the morning of their blood draw [C3, C4].

Thyroglobulin assays are affected too. Biotin causes falsely low thyroglobulin on Siemens platforms, which matters enormously for thyroid cancer patients who rely on thyroglobulin as a surveillance marker [C8].

Where the evidence is weaker

A few nuances deserve mention. Not all assay platforms are affected equally — Abbott Architect and mass spectrometry-based methods are essentially immune to biotin interference [C2]. Patients at the same lab may get completely different results depending on which analyzer is running that day, and few patients know which platform their lab uses.

The dose threshold at which interference becomes clinically meaningful is not precisely defined. Most documented interference occurs at doses ≥5 mg/day, and interference from standard multivitamin doses (30–300 mcg) appears minimal [C7]. But "hair skin and nails" supplements delivering 5,000–10,000 mcg (5–10 mg) per serving clearly cross the threshold [C5].

Clearance time varies. Biotin has a half-life of roughly 2 hours in the body, but it can accumulate with chronic supplementation. Most guidance recommends stopping 2–3 days before a test, though some sources suggest 48 hours is sufficient for typical doses [C7].

Practical guidelines

1. Stop biotin supplements 2–3 days before any thyroid blood test. This includes TSH, free T3, free T4, total T3, total T4, anti-TPO, thyroglobulin, and TRAb tests. Two days is sufficient for most doses; three days is the conservative and safe choice [C7].
2. Check every supplement, not just the obvious ones. Biotin hides in multivitamins, B-complex supplements, prenatal vitamins, and "energy" blends. Read every label before a blood draw [C5].
3. Tell your doctor and lab if you take biotin regularly. They can request a biotin-resistant assay method (such as Abbott Architect or mass spectrometry) if available at your laboratory [C2, C7].
4. Never take biotin the morning of a blood draw. Even a single dose of 5+ mg taken the same morning can distort results within hours [C2].
5. Be especially cautious if you're being evaluated for thyroid cancer. Falsely low thyroglobulin is particularly dangerous in cancer surveillance — it can mask recurrence [C8].
6. The adequate intake for biotin is just 30 mcg/day. High-dose biotin supplements above 5,000 mcg have no demonstrated benefit for hair or nail growth in people without a true biotin deficiency — which is very rare [C5].

Frequently asked questions

Can a regular multivitamin affect my thyroid test? Probably not. Standard multivitamins typically contain 30–300 mcg of biotin, which is well below the range associated with assay interference. The concern is mainly with "hair, skin, and nail" supplements delivering 2,500–10,000 mcg (2.5–10 mg) per serving [C5, C7].

What if I forgot to stop biotin before my test? Should I repeat it? Yes, if you took a high-dose biotin supplement within 48–72 hours of your test, let your doctor know. Depending on your dose and the lab platform, the result may need to be repeated after a sufficient washout period [C7].

My TSH came back low — could biotin explain it? Possibly, if you take high-dose biotin supplements. Your doctor will consider the clinical picture, your symptoms, and your history. A low TSH in an asymptomatic person on a high-dose biotin supplement deserves repeat testing after stopping biotin for 3 days before concluding you have hyperthyroidism [C4].

Which lab platforms are safe even if I take biotin? Assays using the Abbott Architect platform and liquid chromatography with tandem mass spectrometry (LC-MS/MS) are not vulnerable to biotin interference [C2]. If your lab uses these, biotin is less of a concern — but you'd need to confirm with your lab which analyzer is in use.

Does biotin at the 30 mcg level in food affect tests? No. Dietary biotin from eggs, almonds, sweet potato, and other foods contributes micrograms per day — far below any interference threshold [C5].

Bottom line

High-dose biotin supplements cause a predictable, well-documented pattern of false hyperthyroid lab results on streptavidin-based assays — the most commonly used platform in clinical labs [C2, C3]. The FDA has flagged this twice [C1], and the American Thyroid Association considers it a clinically significant patient safety issue [C5, C8]. The rule is simple: stop biotin 2–3 days before any thyroid blood test, and let your care team know you take it.

Sources

1. [C1] U.S. Food and Drug Administration (2017, updated 2019). Biotin (Vitamin B7): Safety Communication — May Interfere with Lab Tests. fda.gov
2. [C2] Ylli D, et al. (2021). Biotin Interference in Assays for Thyroid Hormones, Thyrotropin and Thyroglobulin. Thyroid 31(8):1160–1170. PubMed: 34042535
3. [C3] Meany DL, et al. (2020). Assessment of Biotin Interference in Thyroid Function Tests. Medicine (Baltimore). PMC7478465
4. [C4] Trambas CM, et al. (2019). Clinically Significant Lab Errors due to Vitamin B7 (Biotin) Supplementation: A Case Report Following a Recent FDA Warning. Case Reports in Endocrinology. PMC6802814
5. [C5] American Thyroid Association (2018). Biotin Supplement Use Is Common and Can Lead to the False Measurement of Thyroid Hormone in Commonly Used Assays. Clinical Thyroidology. thyroid.org
6. [C6] Jonklaas J, et al. (2014). Guidelines for the Treatment of Hypothyroidism. Thyroid 24(12):1670–1751. PubMed: 25266247
7. [C7] American Association for Clinical Chemistry (AACC) (2020). AACC Guidance Document on Biotin Interference in Laboratory Tests. myadlm.org
8. [C8] American Thyroid Association (2022). Biotin Use Can Interfere with the Management of Thyroid Diseases, Including Thyroid Cancer. Clinical Thyroidology. thyroid.org

---

For educational purposes only. Not medical advice. Always consult your healthcare provider.